Thromboembolic Prophylaxis with Fondaparinux in Major Orthopaedic Surgery: Outcomes and Costs

Publisher： Karger

E-ISSN： 1424-0556|5|3|121-130

ISSN： 1422-9528

Source： Heart Drug, Vol.5, Iss.3, 2005-06, pp. : 121-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery

By Sullivan S.D.  

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 477-496

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 605-620

Adis International

Access to resources Recommend Favorite

Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients: Interventions and Outcomes

By Eikelboom J.W.  

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 297-306

Adis International

Access to resources Recommend Favorite

Fondaparinux Sodium: A Review of its Use in the Prevention of Venous Thromboembolism Following Major Orthopaedic Surgery

By Neil A. Reynolds   Caroline M. Perry   Lesley J. Scott  

Drugs, Vol. 64, Iss. 14, 2004-01 ,pp. : 1575-1596

Adis International

Access to resources Recommend Favorite

Extended Dalteparin Prophylaxis for Venous Thromboembolic Events: Cost-Utility Analysis in Patients Undergoing Major Orthopedic Surgery

By Dranitsaris George  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 45-58

Adis International

Access to resources Recommend Favorite